P. Schönknecht

S. Olbrich, R. Mergl, U. Hegerl, 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

International quality control survey of neurochemical dementia diagnostics

P. Lewczuk, H. Hampel, J. Kornhuber, 2006, Neuroscience Letters.

Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls

U. Hegerl, M. Strauss, P. Schönknecht, 2010, Neuroscience Letters.

[Neuropsychological correlates of cerebral atrophy in Alzheimer's dementia].

M. Essig, J. Pantel, J. Schröder, 2004, Fortschritte der Neurologie Psychiatrie.

Prevalence of minor depression in elderly persons with and without mild cognitive impairment: a systematic review.

M. Schroeter, R. Mergl, P. Schönknecht, 2014, Journal of affective disorders.

[Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].

M. Essig, J. Pantel, J. Schröder, 2000 .

Mammillary body and hypothalamic volumes in mood disorders.

S. Geyer, S. Schindler, P. Schönknecht, 2022, Journal of psychiatric research.

Postpolio-Syndrom

P. Schönknecht, M. Weber, B. Storch‐Hagenlocher, 2004, Der Nervenarzt.

Between phenomenological and community psychiatry: the Comprehending Anthropology of Jürg Zutt

T. Dening, P. Schönknecht, 2012, History of psychiatry.

Brain arousal regulation as response predictor for antidepressant therapy in major depression

R. Mergl, U. Hegerl, P. Schönknecht, 2017, Scientific Reports.

Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study

Ludovico Minati, Magda Tsolaki, Paolo Maria Rossini, 2016, NeuroImage.

Plasma A (cid:2) 42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study

P. Rossini, J. Molinuevo, O. Blin, 2019 .

Brain morphometry reproducibility in multi-center 3T MRI studies: A comparison of cross-sectional and longitudinal segmentations

Giovanni B. Frisoni, Pierre Payoux, Moira Marizzoni, 2013, NeuroImage.

Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.

Peter Schönknecht, Johannes Pantel, Johannes Schröder, 2005, The American journal of psychiatry.

Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease

U. Hegerl, H. Gertz, P. Schönknecht, 2013, PloS one.

Skin and brain age together: The role of hormones in the ageing process

J. Schröder, E. Kaiser, P. Schönknecht, 2010, Experimental Gerontology.

Brain arousal regulation as response predictor for antidepressant therapy in major depression

R. Mergl, U. Hegerl, P. Schönknecht, 2017, Scientific Reports.

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder

R. Mergl, P. Schönknecht, F. Schmidt, 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease

R. Mergl, H. Gertz, P. Schönknecht, 2014, Neuroscience Letters.

Higher body mass index is linked to altered hypothalamic microstructure

A. Villringer, P. Schönknecht, A. Villringer, 2019, Scientific Reports.

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

H. Möller, H. Hampel, M. Ewers, 2009, The Journal of clinical psychiatry.

The viral accelerated NF-κB pathway drives COVID-19-associated coagulopathy via excessive transcription of tissue factor and plasminogen activator inhibitor 1 – case report

P. Schönknecht, M. Leitzke, 2021, Archives of Clinical and Biomedical Research.

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt–Jakob disease

K. Blennow, H. Hampel, J. Wiltfang, 2006, Neurobiology of Aging.

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

P. Rossini, J. Molinuevo, O. Blin, 2019, Journal of Alzheimer's disease : JAD.

Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease

J. Schröder, P. Schönknecht, C. Sattler, 2012, Psychiatry Research.

Cholesterol in mild cognitive impairment and Alzheimer’s disease in a birth cohort over 14 years

M. Pierer, J. Schröder, P. Schönknecht, 2014, European Archives of Psychiatry and Clinical Neuroscience.

Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls

Peter Schönknecht, Johannes Pantel, Johannes Schröder, 2002, Neuroscience Letters.

Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

et al., Jean-Claude Baron, Karl Herholz, 2002, NeuroImage.

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI

K. Blennow, P. Scheltens, H. Hampel, 2007, Neurology.

Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly

Magda Tsolaki, Paolo Maria Rossini, Frederik Barkhof, 2015, Human brain mapping.

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

P. Rossini, J. Molinuevo, O. Blin, 2019, Journal of Alzheimer's disease : JAD.

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study

F. Jessen, H. Vanderstichele, P. Lewczuk, 2008, Neurobiology of Aging.

Impairment in basal limbic function in schizophrenia during affect recognition

Christoph Stippich, Peter Schönknecht, Eckhard Hempel, 2003, Psychiatry Research: Neuroimaging.

Brain and Body Associations Between EEG-Vigilance and the Autonomous Nervous System Activity During Rest

Christian Sander, Peter Schönknecht, Ulrich Hegerl, 2011 .

A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder

P. Schönknecht, C. Sander, A. Tränkner, 2013, Neuropsychiatric disease and treatment.

Are antidepressants useful in the treatment of minor depression: a critical update of the current literature

R. Mergl, U. Hegerl, P. Schönknecht, 2012, Current opinion in psychiatry.

Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humans.

Gudrun Wagenknecht, Swen Hesse, Marianne Patt, 2014, Nuclear medicine and biology.

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

J. Molinuevo, O. Blin, J. Pariente, 2016, Journal of internal medicine.

Autonomic balance determines the severity of COVID-19 courses

P. Schönknecht, J. Meyer, M. Leitzke, 2020, Bioelectronic medicine.

Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany.

Peter Schönknecht, Johannes Schröder, Pablo Toro, 2009, Journal of Alzheimer's disease : JAD.

Episodic autobiographical memory in normal aging and mild cognitive impairment: A population-based study

Peter Schönknecht, Ulrich Seidl, Johannes Schröder, 2012, Psychiatry Research.

Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1–42)

P. Thomann, J. Schröder, E. Kaiser, 2007, Neuroscience Letters.

Impact of EEG-vigilance on brain glucose uptake measured with [18F]FDG and PET in patients with depressive episode or mild cognitive impairment

Thomas Günther, Christian Sander, Sebastian Olbrich, 2011, NeuroImage.

Distribution of cerebral atrophy assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia

M. Essig, J. Pantel, J. Schröder, 2004, Neuroscience Letters.

Regional cerebral perfusion alterations in patients with mild cognitive impairment and Alzheimer disease using dynamic susceptibility contrast MRI.

Alexander Radbruch, Lars Gerigk, Peter Schönknecht, 2013, Academic radiology.

CSF BIOMARKERS AND EFFECT OF APOLIPOPROTEIN E GENOTYPE, AGE AND SEX ON CUT-OFF DERIVATION IN MILD COGNITIVE IMPAIRMENT

P. Rossini, J. Molinuevo, O. Blin, 2017, Alzheimer's & Dementia.

Test-Retest Stability of the Onset of Depression Inventory

R. Mergl, U. Hegerl, M. Strauss, 2013, Psychopathology.

Onset of Depression Inventory (ODI)--assessment of the speed of onset of depressive episodes.

R. Mergl, U. Hegerl, M. Strauss, 2012, Journal of affective disorders.

Premorbid Personality Traits and Their Course in Mild Cognitive Impairment: Results from a Prospective Population-Based Study in Germany

J. Schröder, P. Schönknecht, C. Sattler, 2011, Dementia and Geriatric Cognitive Disorders.

Reduced cerebrospinal fluid estradiol levels are associated with increased β-amyloid levels in female patients with Alzheimer's disease

J. Pantel, J. Schröder, P. Schönknecht, 2001, Neuroscience Letters.

Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease

H. Hampel, J. Pantel, J. Schröder, 2003, Neuroscience Letters.

Knowing me, knowing you: Spontaneous use of mentalistic language for self and other in autism

U. Frith, Sarah J White, P. Schönknecht, 2020, Autism : the international journal of research and practice.

Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease.

Peter Schönknecht, Johannes Pantel, Elmar Kaiser, 2009, Journal of psychiatry & neuroscience : JPN.

P4-369: Lithium trial in Alzheimer's disease: A randomized, single-blinded, placebo-controlled, parallel group multicentre 10-week study

H. Hampel, M. Ewers, A. Kurz, 2008, Alzheimer's & Dementia.

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease

Uwe Haberkorn, Peter Schönknecht, Aoife Hunt, 2006, Neuropsychiatric disease and treatment.

Subdiagnostische Depressionen

U. Hegerl, P. Schönknecht, Prof. Dr. U. Hegerl, 2009, Der Nervenarzt.

Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy

M. Essig, J. Pantel, J. Schröder, 2003, Psychiatry Research.

Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment.

U. Hegerl, P. Schönknecht, J. Kratzsch, 2015, Journal of affective disorders.

MCI-plus: mild cognitive impairment with rapidprogression.

J. Pantel, Hans Förstl, K. Werheid, 2009 .

[MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods].

J. Pantel, Hans Förstl, K. Werheid, 2009, Deutsche medizinische Wochenschrift.

Diabetes mellitus Type II and cognitive capacity in healthy aging, mild cognitive impairment and Alzheimer's disease

J. Schröder, P. Schönknecht, C. Degen, 2016, Psychiatry Research.

Leichte kognitive Beeinträchtigung mit Vorzeichen rascher Verschlechterung

J. Pantel, Hans Förstl, A. Kurz, 2008, Deutsche medizinische Wochenschrift.

Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization

Matthias L. Schroeter, Uwe Haberkorn, Peter Schönknecht, 2013, Neuroscience Letters.

Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia

P. Thomann, J. Pantel, J. Schröder, 2007, Neuroscience Letters.

Dysthymia Dysthymia

P. Schönknecht, 2012 .

First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18F]Flubatine

Gudrun Wagenknecht, Marianne Patt, Solveig Tiepolt, 2015, NeuroImage.

Progressive medial temporal lobe changes in Alzheimer's disease revealed by quantitative MRI: potential use for monitoring of drug‐related changes

L. Schad, M. Essig, J. Pantel, 2002 .

Cerebrospinal fluid tau protein levels in schizophrenia

J. Pantel, J. Schröder, P. Schönknecht, 2003, European Archives of Psychiatry and Clinical Neuroscience.

Total and phospho-tau ( Thr 181 ) CSF levels in patients with mild cognitive impairment and Alzheimer s disease

J. Pantel, J. Schröder, E. Kaiser, 2022 .

Neurobiological and Psychological Aspects of Mild Cognitive Impairment – Bridging the Gap

P. Schönknecht, 2011 .

Interdisciplinary longitudinal study on adult development and aging (ILSE)

Andreas Zenthöfer, Peter Rammelsberg, Hans-Werner Wahl, 2017 .

Test-retest reproducibility of brain morphometry, diffusion and resting-state fMRI: A 3T consortium study

O. Blin, J. Jovicich, G. Frisoni, 2013, Alzheimer's & Dementia.

CROSS-SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E-ADNI STUDY

P. Rossini, J. Molinuevo, O. Blin, 2014, Alzheimer's & Dementia.

CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study

P. Rossini, J. Molinuevo, O. Blin, 2016 .

[Manic behavior as an autoregulatory attempt to stabilize vigilance].

S. Olbrich, U. Hegerl, P. Schönknecht, 2008, Der Nervenarzt.

A semi-automated algorithm for hypothalamus volumetry in 3 Tesla magnetic resonance images

Christian Lucas, Peter Schönknecht, Julia Wolff, 2018, Psychiatry Research: Neuroimaging.

Neurotropic and psychotropic action of estrogens: implications for Alzheimer's disease

J. Pantel, J. Schröder, K. Beyreuther, 2005 .

Estrogens in Alzheimer’s Disease: A Clinical and Neurobiological Perspective

J. Pantel, J. Schröder, P. Schönknecht, 2005 .

Neural Correlates of Executive Dysfunction in Prodromal and Manifest Alzheimer’s Disease

U. Haberkorn, J. Schröder, P. Schönknecht, 2011 .

Hippocampal glucose metabolism is associated with cerebrospinal fluid estrogen levels in postmenopausal women with Alzheimer's disease

U. Haberkorn, J. Schröder, P. Schönknecht, 2003, Psychiatry Research: Neuroimaging.

P 156 Correlation of regional brain volume and affective disorders 7T MRI based structural analysis of human hypothalami with anxiety symptoms

S. Geyer, S. Schindler, P. Schönknecht, 2017, Clinical Neurophysiology.

Further evidence for a role of S100B in mood disorders: a human gene expression mega-analysis.

M. Schroeter, P. Schönknecht, J. Steiner, 2014, Journal of psychiatric research.

What Does the Speed of Onset of a Depressive Episode Tell Us?

R. Mergl, U. Hegerl, M. Strauss, 2015, Journal of psychiatric practice.

Intensity normalization for intensity-based segmentation of brain structures on 7T MR images

Stefan Geyer, Pierre-Louis Bazin, Robert Turner, 2014 .

Tissue transglutaminase is not a biochemical marker for Alzheimer's disease

T. Arendt, M. Morawski, P. Schönknecht, 2013, Neurobiology of Aging.

Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease

U. Hegerl, H. Gertz, P. Schönknecht, 2013, PLoS ONE.

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

J. Molinuevo, J. Jovicich, G. Frisoni, 2019, Journal of Alzheimer's disease : JAD.

Association of Speed of Onset and Speed of Recovery of Depressive Episodes in Patients with Major Depression

R. Mergl, U. Hegerl, M. Strauss, 2014, Psychopathology.

Onset of Depression Inventory (ODI)--assessment of the speed of onset of depressive episodes.

R. Mergl, U. Hegerl, M. Strauss, 2012, Journal of affective disorders.

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease

U. Haberkorn, J. Schröder, P. Schönknecht, 2006, Neuropsychiatric disease and treatment.

Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study

P. Rossini, O. Blin, F. Barkhof, 2016, NeuroImage.

Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany.

J. Schröder, P. Schönknecht, P. Toro, 2009, Journal of Alzheimer's disease : JAD.

[Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].

J Schröder, P Schönknecht, J. Pantel, 2005, Fortschritte der Neurologie-Psychiatrie.

Goethe: A bipolar personality? Periodicity of affective states in Johann Wolfgang von Goethe as reflected by Paul Julius Möbius

P. Schönknecht, H. Steinberg, 2020, Journal of medical biography.

Onset-of-Depression-Inventory Assessment of the speed of onset of depressive episodes by using ODI

R. Mergl, U. Hegerl, M. Strauss, 2011, Nervenheilkunde.

Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1–42)

P. Thomann, J. Schröder, E. Kaiser, 2007, Neuroscience Letters.

Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease

F. Jessen, I. Heuser, H. Hampel, 2010, Psychiatry Research: Neuroimaging.

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

H. Möller, H. Hampel, M. Ewers, 2009, The Journal of clinical psychiatry.

Intracortical EEG-vigilance stages and the autonomous nervous system

S. Olbrich, U. Hegerl, P. Schönknecht, 2009 .

MCI-plus: leichte kognitive Beeinträchtigung mit rascher Progredienz

J. Pantel, Hans Förstl, K. Werheid, 2009, Deutsche medizinische Wochenschrift.

E-mental health in Germany — what is the current use and what are experiences of different types of health care providers for patients with mental illnesses?

M. Löbner, P. Schönknecht, M. Bleckwenn, 2023, Archives of Public Health.

MCI-plus: leichte kognitive Beeinträchtigung mit rascher Progredienz

J. Pantel, Hans Förstl, K. Werheid, 2009, Deutsche medizinische Wochenschrift.